2000

Scientific programme

Lipid lowering in stroke prevention

Chairpersons: Pierre Amarenco (Paris), Andreas Terent (Uppsala)

• Lipid lowering in stroke prevention, an overview – Pierre Amarenco (Paris)  
  
• Lipid lowering in stroke prevention – a new randomised controlled trial of cerivastin – Magnus von Arbin (Danderyd)  
  
• A critical comment on lipid lowering in stroke prevention – Philip Bath (Nottingham)

New strategies for stroke prevention

Chairpersons: Kenneth Pehrsson (Stockholm), Christian Carlström (Stockholm)

• Thrombin inhibitors – can they replace warfarin in stroke prevention – Hans Johnsson (Stockholm)  
  
• The effect of an ACE inhibitor, ramipril, on stroke events in high risk patients – Peter Sleight (Oxford)  
  
• The effect of a calcium antagonist, nifedipine, on stroke and other events in hypertensive patients – Morris Brown (Cambridge)  
  
• A critical comment – Jesper Petersson (Malmö)

Special lecture     

Chairpersons: Bo Norrving (Lund), Nils Gunnar Wahlgren (Stockholm)

• Lacunar strokes- do trial results apply to them? – Julien Bogousslavsky (Lausanne)

Thrombolytic therapy in acute stroke

Chairpersons: Markku Kaste (Helsinki), Lars Thomassen (Bergen)

• An institutional protocol for thrombolytic therapy : The Heidelberg experience – Werner Hacke (Heidelberg)  
  
• Updated systematic review of randomised controlled trials of tPA in acute stroke – Joanna Wardlow (Edinburgh)  
  
• Systematic review of post-trial experiences of tPA in acute stroke – Martin Grond (Cologne)  
  
• Improvements in selection of stroke patients for thrombolysis: MR diffusion and perfusion imaging – Stig Holtås (Lund)  
  
• SITS International Stroke Thrombolysis Register – Nils Gunnar Wahlgren (Stockholm)  
  
• A review of local criteria for thrombolysis treatment in acute stroke patients in centres affiliated with the International Stroke Thrombolysis Register – Risto Roine (Helsinki)  
  
• Controversies and unresolved issues – Richard Lindley (Edinburgh)

Update on Carotid surgery

Chairpersons: Jesper Swedenborg (Stockholm), Jan Malm (Umeå)

• Selecting patients for Carotid surgery: Individual estimation of benefit and risk – Peter Rothwell (Edinburgh)  
  
• The Carotid Surgery Register – Viveka Monti (Stockholm)

Acute management of stroke – a neuroprotective treatment and metabolic control

Chairpersons: Lászlo Csiba (Debrecen), Per Wester (Umeå)

• Clomethiazole in acute stroke – Nils Gunnar Wahlgren (Stockholm)  
  
• Overview of neuroprotective trials – Kennedy Lees (Glasgow)
   
• Blood pressure in acute stroke- evidence from the INWEST trial – Niaz Ahmed (Stockholm)  
  
• Blood pressure in acute stroke and functional recovery – Angel Chamorro (Barcelona)  
  
• Blood pressure in acute stroke- a systematic review – Philip Bath (Nottingham)  
  
• Metabolic control in acute stroke – Bo  Norrving (Lund)

Special lecture

Chairpersons: David Russell (Oslo), Nils Gunnar Wahlgren (Stockholm)

• Ultrasound characterisation of carotid artery plaques – Michael Hennerici (Mannheim)

Antiplatelet treatment for stroke prevention- where do we go from now?

Chairpersons: Karsten Overgaard (Copenhagen), Hans Göran Hårdemark (Uppsala)

• Antiplatelet therapy for vascular events: Recommended therapy in the perspective of stroke and TIA trials – Jaques De Keyser (Groningen)  
  
• Management of vasodilation headache with dipyridamole – Arne Lindgren (Lund)  
  
• Combined clopidogrel- aspirin treatment, early experiences – Georgios Kaponides (Stockholm)

New frontiers in stroke research

Chairpersons: Tommy Olsson (Umeå), Arne Lindgren (Lund)

• Formations of new neurons – Peter S Eriksson (Gothenburg)  
  
• Formations of new endothelial cells – Christian Carlström (Stockholm)  
  
• New frontiers for transcranial Doppler- implications for treatment? – David Russell (Oslo)